ライフサイエンスコーパス: coronary calcification

1 imarily to detect and quantify the extent of coronary calcification.

2 sion tomography was associated with incident coronary calcification.

3 ss with an osteoblastic component resembling coronary calcification.

4 ely correlated with global plaque volume and coronary calcification.

5 enuates the effects of insulin resistance on coronary calcification.

6 ilable and is limited in patients with dense coronary calcification.

7 nce daily) did not affect the progression of coronary calcification.

8 py but did not result in less progression of coronary calcification.

9 ween antibodies to human HSP60 and levels of coronary calcification.

10 ose-response manner, with elevated levels of coronary calcification.

11 igh CRP levels are associated with increased coronary calcification.

12 to quantify noncoronary atherosclerosis and coronary calcification.

13 nd correlated mineral and bone findings with coronary calcifications.

14 ommon in femoral arteries (54%), followed by coronary calcification (38%) and carotid plaques (34%).

15 From a total of 383 vessels without any coronary calcification, 47 (12%) presented with >or=50%

16 on, coronary heart disease risk factors, and coronary calcification (a marker of atherosclerosis) wer

17 There is substantial evidence that coronary calcification, a marker for the presence and qu

18 ee survival is also reduced in patients with coronary calcification after both percutaneous coronary

19 The prevalence of coronary calcification (Agatston score >0) in these 4 et

20 ght to determine the frequency and impact of coronary calcification among patients undergoing percuta

21 After similar adjustments, the amount of coronary calcification among those with an Agatston scor

22 no large population-based studies comparing coronary calcification among US ethnic groups.

23 There was a significant correlation between coronary calcification and breast artery calcification (

24 studies showing strong correlations between coronary calcification and coronary heart disease events

25 HSP65 are associated with elevated levels of coronary calcification and correlated with H pylori infe

26 r prevention of hyperphosphatemia may reduce coronary calcification and its associated morbidity and

27 our understanding of the pathophysiology of coronary calcification and its clinical significance.

28 sought to determine the relationship between coronary calcification and plaque progression in respons

29 was also a significant relationship between coronary calcification and postmenopausal calcification

30 xamined cross-sectional associations between coronary calcification and potential risk factors in hea

31 y and antioxidants retard the progression of coronary calcification and prevent atherosclerotic cardi

32 lipid-lowering therapy slows progression of coronary calcification and prevents coronary artery dise

33 e diabetes therapy reduces the prevalence of coronary calcification and progression of atherosclerosi

34 be worth investigating the relation between coronary calcification and risk factors not quantified i

35 s of the proximal coronary arteries, detects coronary calcifications and has been demonstrated to be

36 h lower eGFR were more likely to have severe coronary calcifications and higher usage of atherectomy.

37 computed tomography to assess the number of coronary calcifications and the coronary artery calcific

38 he 10-year Framingham risk index, histologic coronary calcification, and culprit plaque morphology in

39 o have higher baseline comorbidities, severe coronary calcification, and higher atherectomy usage, ye

40 t left ventricular ejection fraction, severe coronary calcification, and the presence of medium/large

41 nger lesion lengths, multivessel PCI, severe coronary calcification, and thrombectomy device use were

42 nsibility; 2) aortic pulse wave velocity; 3) coronary calcification; and 4) brachial artery endotheli

43 er consensus on criteria for abnormality for coronary calcification are advised.

44 Framingham risk index and the measurement of coronary calcification are distinct methods of assessing

45 This may justify the use of coronary calcification as a surrogate marker for coronar

46 a single imaging session, and the volume of coronary calcification as quantified with this technique

47 e risk for coronary artery disease underwent coronary calcification assessment with cardiac CT angiog

48 tals was generally associated with extent of coronary calcification at baseline and follow-up.

49 omputed tomography (EBCT) is used to measure coronary calcification but not for aortic valve calcific

50 thy by evaluating heart failure patients for coronary calcification (CC).

51 orldwide, are associated with progression in coronary calcification, consistent with acceleration of

52 duals with diabetes mellitus and established coronary calcification (coronary calcium score > 10), bu

53 The relation among coronary calcification, coronary stenoses and coronary h

54 Intravascular ultrasound analysis shows that coronary calcification correlates with plaque burden but

55 Coronary calcification correlates with the extent of ath

56 ovascular risk profile, so that the risk for coronary calcifications could be considered similar betw

57 This review examines the power of coronary calcification detected by electron beam compute

58 Coronary calcification detected by electron beam compute

59 ention studies can use the rate of change of coronary calcification detected by serial electron beam

60 Coronary calcification determined by electron beam compu

61 The absence of coronary calcification does not exclude obstructive sten

62 beam CT scans were obtained in patients with coronary calcification (group A) or known risk factors f

63 lar, left main CAD (h2=0.49+/-0.12; P=0.01), coronary calcification (h2=0.51+/-0.17; P=0.001), and ec

64 The predictive power of coronary calcification has been shown to exceed that of

65 Most data on coronary calcification have been obtained with electron-

66 Efforts to refine statin eligibility via coronary calcification have been studied in white popula

67 Coronary calcification hinders stent delivery and expans

68 Using computed tomography, we measured coronary calcification in 6814 white, black, Hispanic, a

69 ronic stress burden were not associated with coronary calcification in a multiethnic sample of asympt

70 risk factor-adjusted relative prevalences of coronary calcification in men for the top fourth categor

71 (> or = 14 drinks/week) was associated with coronary calcification in other race/sex subgroups.

72 ; p = 0.025) or when we further adjusted for coronary calcification in participants with positive Aga

73 een (18)F-fluoride uptake and progression of coronary calcification in patients with clinically stabl

74 inflammatory mediators with the severity of coronary calcification in RA and control subjects was ex

75 2-/3-dimensional vascular ultrasound and/or coronary calcification in the PESA (Progression of Early

76 on may explain why type 1 diabetes increases coronary calcification in women relatively more than in

77 no significant differences in the amount of coronary calcifications in patients with or without migr

78 of future cardiac events, presumably because coronary calcification is a marker for overall atheroscl

79 Although coronary calcification is associated with worse cardiova

80 The prevalence and severity of coronary calcification is increased in patients with est

81 Coronary calcification is seen as an aetiopathological e

82 sociation of mHSP65 antibodies with elevated coronary calcification levels was independent of CAD ris

83 e investigators believe that the presence of coronary calcification may stabilize the atherosclerotic

84 (mean age, 42 years; 79% male; 66 [15%] had coronary calcification; mean [SD] predicted 10-year coro

85 verity, distribution of lesions, presence of coronary calcification, morphology of stenoses, and anat

86 e in FRS, after controlling for knowledge of coronary calcification, motivation for change, and multi

87 tricted the analysis to participants without coronary calcification (n = 222; OR: 4.77; 95% CI: 1.22

88 Patients with coronary calcification on EID-CT (collimation, 192x0.6 m

89 Little is known about the impact of coronary calcification on outcomes after PCI for patient

90 k population, including subjects with severe coronary calcification or prior stent placement.

91 l fibrillation, but not for high heart rate, coronary calcification, or obesity.

92 VLDL size were significantly associated with coronary calcification (P = 0.001, 0.02, and 0.04, respe

93 plaque erosion (n=22) had significantly less coronary calcification (P=0.003) and lower Framingham ri

94 t reliable predictors of the severity of the coronary calcification percentile.

95 The extent and progression of coronary calcification predict cardiovascular events.

96 interest because the presence and burden of coronary calcification provide direct evidence of the pr

97 nary segments with more rapid progression of coronary calcification, providing important insights int

98 NOTIFY-1 (Incidental Coronary Calcification Quality Improvement Project) was

99 Coronary calcification quantified by EBCT is closely rel

100 gham risk index and the extent of histologic coronary calcification (r=0.35, P=0.002).

101 centrations attenuated the increased risk of coronary calcification related to insulin resistance.

102 nt pre-test probabilities and in presence of coronary calcification remains uncertain.

103 or women with none, minimal, and significant coronary calcification, respectively.

104 = 0.50), CRP (rho = 0.29), ESR (rho = 0.26), coronary calcification (rho = 0.26), and Disease Activit

105 ded to establish the predictive power of the coronary calcification score for clinical events and the

106 Leslee Shaw and colleagues showed that the coronary calcification score predicted total mortality w

107 There was no correlation between the coronary-calcification score and the scores measuring de

108 U]; P < 0.001) and more rapid progression of coronary calcification scores (39 AU [interquartile rang

109 Using coronary calcification screening to motivate patients to

110 ars to be comparable to electron-beam CT for coronary calcification screening, except in subjects wit

111 ents for identification and/or management of coronary calcification, stenotic or obstructive disease,

112 P65 antibodies are associated with levels of coronary calcification that appear to reflect preclinica

113 differences in the presence and quantity of coronary calcification that were not explained by corona

114 he coronary arteries and the relationship of coronary calcification to standard coronary disease risk

115 ce of coronary atherosclerosis by imaging of coronary calcification using cardiac computed tomography

116 We measured coronary calcification using electron-beam dual-source c

117 Quantification of coronary calcification via electron beam computed tomogr

118 present sample, the odds ratio of having any coronary calcification was 2.57 (95% confidence interval

119 up (55% women, 45% Black), the prevalence of coronary calcification was 8% for consumption of 0 drink

120 In this prospective cohort, the presence of coronary calcification was associated with an independen

121 yesian network that predicts the presence of coronary calcification was constructed.

122 ts had significant angiographic disease, and coronary calcification was detected in 404, yielding a s

123 The presence of coronary calcification was evaluated.

124 The extent of coronary calcification was more pronounced with older ag

125 In 37 (61.7%) cases, mild to severe coronary calcification was observed, and 50 (83.3%) had

126 Coronary calcification was present in one patient who ha

127 Coronary calcification was quantified by measuring calci

128 Coronary calcification was the major cause of false-posi

129 d with whites, the relative risks for having coronary calcification were 0.78 (95% CI 0.74 to 0.82) i

130 The mean patient age and prevalence of coronary calcification were similar in the 2 groups (53+

131 CAC score and number of coronary calcifications were directly related to age-adj

132 clerosis (MESA), a population-based study of coronary calcification, were used to investigate accultu

133 and socioeconomic position as predictors of coronary calcification within 2553 non-Hispanic whites,

134 differences in the prevalence and amount of coronary calcification within whites, Chinese, blacks, a